NCT00410605 2017-09-01
Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
4 trialsNCT00473590 2017-06-14
AMBER
Genentech, Inc.
Phase 2 Completed
NCT02079519 2014-07-08
A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma
Hoffmann-La Roche
Phase 2 Terminated
NCT00022607 2013-06-24
Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Completed